Next Article in Journal
Spermatogenic Activity and Sperm Traits in Post-Pubertal and Adult Tomcats (Felis catus): Implication of Intra-Male Variation in Sperm Size
Next Article in Special Issue
Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders
Previous Article in Journal
PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells
Previous Article in Special Issue
Adult Upper Cortical Layer Specific Transcription Factor CUX2 Is Expressed in Transient Subplate and Marginal Zone Neurons of the Developing Human Brain
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Rab27a-Dependent Paracrine Communication Controls Dendritic Spine Formation and Sensory Responses in the Barrel Cortex

1
Departments of Neurosurgery, and Cellular & Molecular Physiology, School of Medicine, Yale University, 333 Cedar Street, New Haven, CT 06520-8082, USA
2
Department of Psychology, Florida State University, Tallahassee, FL 32306, USA
*
Author to whom correspondence should be addressed.
Cells 2021, 10(3), 622; https://doi.org/10.3390/cells10030622
Submission received: 25 February 2021 / Revised: 4 March 2021 / Accepted: 5 March 2021 / Published: 11 March 2021
(This article belongs to the Special Issue Molecular and Cellular Mechanisms of Neocortical Circuit Formation)

Abstract

:
Rab27a is an evolutionarily conserved small GTPase that regulates vesicle trafficking, and copy number variants of RAB27a are associated with increased risk of autism. However, the function of Rab27a on brain development is unknown. Here, we identified a form of paracrine communication that regulates spine development between distinct populations of developing cortical neurons. In the developing somatosensory cortex of mice, we show that decreasing Rab27a levels in late-born pyramidal neurons destined for layer (L) 2/3 had no cell-autonomous effect on their synaptic integration but increased excitatory synaptic transmission onto L4 neurons that receive somatosensory information. This effect resulted in an increased number of L4 neurons activated by whisker stimulation in juvenile mice. In addition, we found that Rab27a, the level of which decreases as neurons mature, regulates the release of small extracellular vesicles (sEVs) in developing neurons in vitro and decreasing Rab27a levels led to the accumulation of CD63-positive vesicular compartments in L2/3 neurons in vivo. Together, our study reveals that Rab27a-mediated paracrine communication regulates the development of synaptic connectivity, ultimately tuning responses to sensory stimulation, possibly via controlling the release of sEVs.

1. Introduction

Rab27 is a member of the small GTPase Rab family, which consists of master regulators of intracellular membrane trafficking in all eukaryotic cells [1,2,3]. A single Rab27 isoform is present in invertebrates and two isoforms, Rab27a and Rab27b, are present in vertebrates [4] and are involved in the exocytic pathway [5,6]. Rab27a was the first identified Rab protein whose dysfunction leads to a human hereditary disease, type 2 Griscelli syndrome [7]. This disease is mostly studied for immunodeficiency and associated hemophagocytic lymphohistocytosis that lead to severe neurological abnormalities [8]. RAB27A copy number variants have also been reported in sporadic cases of autism and are thought to play a role in the etiology of simplex autism [9]. In Caenorhabditis (C.) elegans and in squid, Rab27 is expressed in neurons and regulates synaptic transmission [10,11] and knockout of Rab27 in Drosophila leads to an altered sleep phenotype [12], suggesting important functions of Rab27 in the nervous system of these organisms. In mammalian brains, the levels of Rab27a are developmentally regulated [13]. However, a role of Rab27a in the establishment of synaptic circuits in the mammalian brain remains unknown.
Here, we investigated the role of Rab27a on the synaptic integration of cortical pyramidal neurons in mice. Given the high expression of RAB27A in the developing cortex [14], we used in utero electroporation to knockdown Rab27a expression in late-born pyramidal neurons that populate layer (L) 2/3 of the somatosensory cortex. We found no cell-autonomous effect of Rab27a knockdown (~50% decrease) on the synaptic integration of these cortical neurons. Nevertheless, we next examined whether Rab27a could have an effect in nearby non-electroporated neurons because Rab27a has been shown to control the release of intraluminal vesicles into the extracellular milieu, called small extracellular vesicles (sEVs) or exosomes, by regulating multivesicular body (MVB) docking and fusion with the plasma membrane [15,16,17,18,19,20,21]. There is accumulating evidence that sEVs have important roles during brain development, including the regulation of spine development, which was reported in cultured mouse and human neurons [22,23] (for reviews see References [24,25]). We thus examined the dendritic spine properties and synaptic activity of non-electroporated neurons. More specifically, we examined earlier born neurons that populate L4 and are thus in close contact with L2/3 electroporated neurons during perinatal development, but do not receive synaptic inputs from L2/3 neurons. Rab27a knockdown led to an increase in spine density and excitatory synaptic activity in non-electroporated L4 neurons that was accompanied by an increased number of activated neurons following whisker stimulation. This effect also led to the accumulation of MVBs in electroporated neurons in vivo, consistent with a decreased release of sEVs that we observed in vitro. Collectively, we identified a Rab27a-dependent release of sEVs that coordinates synapse development between distinct populations of cortical neurons, ultimately tuning responses to sensory stimulation.

2. Material and Methods

2.1. Animals

Research protocols were approved by the Yale University Institutional Animal Care and Use Committee. All experiments were performed on CD1 (Charles River) mice of either gender.

2.2. In Utero Electroporation (IUE) and Plasmids

Each DNA plasmid was diluted in sterile phosphate buffer saline (PBS) (pH 7.4) to a final concentration listed in Supplementary Table S1. The Dcx-Cre and pCAG-tdTomato plasmids were from References [26,27]. Timed pregnant mice at embryonic day (E) 13.5 or E15.5 were anesthetized with isoflurane. After exposing the uterine horns, ~1 μL of DNA solution, containing 0.01% fast green added as an injection tracer, was injected into the lateral ventricle via a pulled glass capillary. PBS-soaked tweezer-type electrodes (model 520, BTX) were then positioned on the head of the fetuses across the uterine wall and 6 square-pulses at 36 V (E13.5) or 42 V (E15.5), 50 ms duration, 950 ms intervals, were applied using a pulse generator (ECM830, BTX). Mice were prescreened for successful electroporation by detecting the expression of fluorescent protein markers on a fluorescence-enabled stereo microscope (SZX16, Olympus).

2.3. Electrophysiology

Slice physiology: Slices were obtained from P14 CD1 mice containing DsRed-positive neurons in layer (L) 4/5 and green fluorescent protein (GFP) expression in L2/3 cortical neurons generated by IUE at E13.5 and E15.5, respectively. On the day of the recording, mice were anesthetized with isoflurane and decapitated. Brains were quickly removed and immersed in ice-cold high-sucrose solution containing (in mM): 220 sucrose, 2.5 KCl, 6 MgCl2, 1 CaCl2, 1.23 NaH2PO4, 26 NaHCO3, and 10 glucose (gassed with 95% O2/5% CO2; 300 mOsm), or artificial cerebrospinal fluid (ACSF): 124 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 26 NaHCO3, 10 dextrose, 2 CaCl2, 0.4 ascorbate, 4 Na-lactate, and 2 Na-pyruvate (290 ± 5 mOsm, pH 7.2). Coronal brain slices (300–350 µm-thick) were cut in ice-cold solution using a vibratome (Vibratome 1000) and incubated in ACSF at 32 °C for 45 min prior to returning to room temperature (20–25 °C). The recording solution was the ACSF solution detailed above or an ACSF solution containing (in mM): 124 NaCl, 2.5 KCl, 2 MgCl2, 2 CaCl2, 1.23 NaH2PO4, 26 NaHCO3, and 10 glucose (gassed with 95% O2/5% CO2; 300 mOsm). Experiments were performed at 30–33 °C using a dual-channel heat controller (Warner Instruments, Hamden, CT, USA). GFP- or tdTomato-expressing neurons were visualized with epifluorescence on an Olympus BX51WI microscope with a 40x water immersion objective (Olympus; LUMPlanFL/IR). Pipettes used for whole-cell recordings were pulled from thin-walled borosilicate glass capillary tubes (World Precision Instruments) using a P-97 micropipette puller (Sutter Instruments, Novato, CA, USA) and had resistances ranging from 4 to 7 MΩ when filled with a pipette solution containing (in mM) 145 K-gluconate, 1 MgCl2, 10 HEPES, 1.1 EGTA, 2 Mg-ATP, 0.5 Na2-GTP, and 5 Na2-phosphocreatine, or 4 KCl, 125 K-gluconate, 10 HEPES, 10 di-Tris-phosphocreatine, 1 EGTA, 0.2 CaCl2∙2H2O, 4 Na2-ATP, and 0.3 Na-GTP (pH 7.3 with KOH; 290–295 mOsm). Recordings were acquired with an amplifier (Axopatch 200B from Molecular devices or EPC-10 from HEKA Instruments), low-pass filtered at 5 kHz, 10x gained, and digitized at 20 kHz (Digidata 1320; Molecular Devices). Neurons, for which the series resistance was >20 MΩ and changed by >15%, were excluded from the analysis. Resting membrane potential was measured in current clamp mode without current injection within 5 s after break-in. Spontaneous synaptic currents were recorded in voltage-clamp mode for 5 min with cells clamped at −70 mV. Data were analyzed using Clampfit (Version 10; Molecular Devices) or PatchMaster 2.20 (HEKA Instruments).
Paired pulse recording in vitro: Neurons dissected from E15 cortices were cultured and nucleofected with ChR2-mCherry and Rab27a shRNA. ChR2-mCherry and empty shRNA vector (EV) were transfected as control. Paired pulse-evoked postsynaptic currents were recorded from non-fluorescent neurons receiving inputs from ChR2-mCherry-expressing neurons. Laser stimulation (470 nm) of 10 ms with an interval of 100 ms was used to activate presynaptic ChR2-expressed neurons and evoke postsynaptic currents on recorded neurons.

2.4. Spine Analyses

Spine analysis was performed blindly using the automated spine identifier in NeuronStudio [28] on confocal Z-stack images (0.2 µm-steps) acquired with a 60X oil Olympus Uplan SAPO (N.A. 1.35) objective on an Olympus Fluoview 1000 confocal microscope. Spine density and shape, including thin, stubby, and mushroom, were analyzed on two to three 100 μm-long segments of a secondary dendrite per neuron. Thin spines have a thin, long neck, and a small bulbous head, whereas mushroom spines have a larger head. Stubby spines are devoid of a neck and are prominent between postnatal development [29]. A mushroom type is defined as a spine with a head to neck ratio > 1.1 and a head diameter > 0.35 µm.

2.5. Novel, Enriched Environment for Whisker Stimulation

Littermate postnatal day (P) 21 mice that were electroporated at E15.5 with shRNA vectors were placed in a novel, enrichment environment for 2 h in the dark. After brain dissection, fixation, and slicing, coronal sections were immuno-stained for VGLUT2 and c-fos.

2.6. Immunostaining in Fixed Sections and Analysis

Brains were serially cut into 50 μm-thick coronal sections using a freezing microtome and stored in PBS + 0.01% sodium azide. For staining, free-floating sections were washed in PBS + 0.1% Triton X-100 (PBS-T) for 2 × 10 min and permeabilized in PBS + 0.3% Triton X-100 for 20 min. Sections were then incubated in blocking buffer (5% goat serum + 0.3% BSA + 0.3% Triton X-100 in PBS) for 1 h at room temperature, followed by incubation in primary antibodies (Supplementary Table S2) diluted in blocking buffer overnight at 4 °C. The following day, sections were washed in PBS-T three times for 10 min each and incubated in secondary antibodies (Supplementary Table S2) for 1 h at room temperature. Sections were then washed in PBS-T three times for 10 min each, incubated in DAPI for 10 min, rinsed in PBS, before being air-dried and cover-slipped with mounting media (ProLong Diamond Antifade Mounting medium; Invitrogen). Quantification of Rab27a and CD63 immunostainings were performed using two methods using NIH Image J software on Z-stack images obtained with a 60x (oil) objective on an Olympus Fluoview 1000 confocal microscope. One method measured the mean gray value of CD63 and Rab27a fluorescence in tdTomato-positive soma. A second method measured the number of pixels for each CD63 and Rab27a puncta above a set threshold and for tdTomato-positive soma to obtain surface area. Both methods gave similar results (data not shown). In addition, soma size was not affected by Rab27a shRNA and the fluorescence data were thus not divided by the measured soma size.

2.7. Neuronal Culture

Cerebral cortices from E15 mice (for nucleofection prior to culturing) were isolated after removing meninges and placed in ice-cold Hibernate E (Invitrogen, #A12476-01) supplemented with B27 (Invitrogen, #17504-044). The cortices were then incubated in pre-warmed and activated papain digestion solution (Worthington, #LK003150). After a 15 min digestion, neurons were dissociated and plated in MEM medium (Invitrogen, #11095-080), supplemented with 5% FBS (Invitrogen, #16000) and 0.6% glucose (Sigma, # G8769). Plating medium was replaced with neurobasal medium (Invitrogen, #21103-049) supplemented with B27 and GlutaMax-1 (Invitrogen, #35050-061) after neurons have attached. The medium was changed every 3 days.

2.8. Western Blot

Extracellular vesicles were lysed in reducing sample buffer (0.25 M Tris–HCl (pH 6.8), 40% glycerol, 8% SDS, 5% 2-mercaptoethanol, and 0.04% bromophenol blue) or non-reducing sample buffer (without 2-mercaptoethanol, for CD63), and then boiled for 5 min. Primary neurons were homogenized in RIPA buffer, 1x Halt Protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific, Waltham, MA, USA), 5 mM EDTA, and 20 units/mL DNase I (Roche). All lysates were run on Tris-glycine gradient gels (Bio-Rad; #456-1084). Proteins were transferred to PVDF and blocked in 5% milk and incubated with primary antibodies in 0.25% BSA (concentrations of primary antibody are listed in Supplementary Table S2). HRP-conjugated anti-rabbit or anti-mouse were used as secondary antibodies. All density measurements were performed by using NIH Image J software.

2.9. Isolation of Small Extracellular Vesicles

We used sequential centrifugation procedures and filtration. Conditioned medium was first centrifuged at 300 g for 10 min at 4 °C to remove detached cells, followed by a 0.22 μm filtration, an ultracentrifugation at 120,000 g for 70 min at 4 °C using a fixed-angle bucket rotor (Beckman), and a washing step in PBS to eliminate contaminating proteins. Pellets were re-suspended in 50 µL PBS by syringing through a sterile 27-gauge needle to prevent clumping together. The isolated vesicular fractions were immediately characterized or stored at 80 °C for later use (no more than 1 week). The vesicle size distribution was accessed by nanoparticle tracking analysis with NanoSight NS300 (Malvern Panalytical Ltd., Malvern, UK).

2.10. Nucleofection of Primary Neurons

Mouse Neuron Nucleofector kit (Lonza, #VPG-1001) was used for nucleofection as previously described [30]. Briefly, following microdissection of the cortices and neuron dissociation, 4–6 × 106 cells were spun down and re-suspended in nucleofection solution with 3–5 µg plasmids. DNA was transfected by nucleofector® program 0–005. Neurons were then plated in MEM medium supplemented with 5% FBS and 0.6% glucose and maintained in neurobasal medium supplemented with B27 and GlutaMax-1.

2.11. Electron Microscopy

Electron microscopy (without additional staining) was performed by the imaging core facility in the department of Physiology at Yale. Purified vesicles were resuspended in 4% wt/vol paraformaldehyde in phosphate buffered solution (pH 7.4) and embedded for 20 min at room temperature in a formvar-carbon-coated grid. The embedded vesicles were washed in phosphate-buffered saline (PBS), fixed in 1% gluteraldehyde for 5 min, and stained with saturated aqueous uranyl oxalate. Samples were subsequently embedded in 0.4% wt/vol uranyl acetate and 1.8% wt/vol methylcellulose on ice for 10 min. Samples were dried at room temperature prior to visualization with a Carl Zeiss 910 electron microscope (Carl Zeiss Microscopy, Thornwood, NY, USA).

2.12. Statistical Analyses

Data were plotted in Prism 7 (GraphPad Software, Inc., San Diego, CA, USA). Statistical significance was determined using the unpaired two-tailed Student’s t-test or one-way analysis of variance (ANOVA) with Tukey’s post-hoc test with p < 0.05 for significance for all experiments. Data are presented as mean ± SEM including the data points in some of the plots. Each experiment was reproduced at least three times, e.g., three mice or three sets of culture. The Student t-tests were all two-sided and unpaired. Normality tests were performed using the D’Agostino-Pearson omnibus test.

3. Results

3.1. Rab27a Is Present in Developing Cortical Neurons, but Decreasing Rab27a Expression has no Cell-Autonomous Effect on the Synaptic Integration of L2/3 Pyramidal Neurons

To examine the function of Rab27a on the development of cortical neurons, we decreased Rab27a levels using a knockdown strategy in vivo with in utero electroporation (IUE, Figure 1A). We first tested the knockdown efficiency of shRNA vectors (conditional pSico [31] co-expressed with pCAG-Cre) against Rab27a in cultured cortical neurons. Three days following nucleofection of cultured neurons, Rab27a shRNA significantly decreased Rab27a levels compared to a control empty vector (Figure 1B). In addition, we found no compensatory increase in Rab27b in the Rab27a shRNA condition (Supplementary Figure S1). We then used IUE to express conditional Rab27a shRNA plasmid or an empty vector control in radial glia at embryonic day (E) 15–15.5, targeting late-born pyramidal neurons that populate layer (L) 2/3 in the somatosensory cortex. In both conditions, we co-electroporated an inducible GFP plasmid and a vector encoding Cre recombinase (Cre) under the neuronal promoter doublecortin (Dcx) to induce recombination selectively in developing neurons, but not in radial glia [26]. Immunostaining for Cre showed that nearly all electroporated cells displayed Cre expression (Figure 1C). We also immuno-stained for Rab27a in both control and Rab27a shRNA conditions (Figure 1D). Analysis of Rab27a fluorescence per cell or Rab27a puncta size revealed a significant decrease (47%) of Rab27a expression in the Rab27a shRNA condition (Figure 1E). Decreased Rab27a expression did not alter the placement of L2/3 pyramidal neurons (Figure 1F). Whole-cell patch-clamp recordings of electroporated neurons revealed that Rab27a shRNA did not alter their resting membrane potential, input resistance, and intrinsic excitability (Figure 1G,H). In addition, the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) was not altered by Rab27a knockdown (Figure 1I). Since dendritic spines are the unitary sites of excitatory synaptic inputs, we examined their density. Consistent with the sEPSC data, knocking down Rab27a did not alter the density and shape distribution of spines in electroporated neurons (Figure 1J). Considering that Rab27 regulates synaptic release in C. elegans and squid [10,11], we examined whether Rab27a shRNA would affect synaptic vesicular release from cortical neurons in vitro. We co-electroporated channelrhodopsin (ChR2) with the shRNA and induced action potentials followed by vesicular release from neurons expressing Rab27a shRNA. Using patch-clamp recordings of neighboring non-electroporated neurons in the same cultures (Figure 1K), we found that Rab27a shRNA did not affect paired pulse ratio, a read-out of release probability (Figure 1L,M). Collectively, these data suggest that decreasing Rab27a levels in cortical neurons did not affect their migration, spine development, and synaptic connectivity in a cell-autonomous manner.

3.2. Decreasing Rab27a Levels in L2/3 Neurons Increases L4 Neurons’ Excitatory Synaptic Inputs and Activation by Whisker Stimulation

Considering Rab27a’s role in vesicular trafficking, including the fusion of MVB resulting in the release of intraluminal vesicles (ILs) into the extracellular space that are then called sEV or exosomes [15,16,17,18,19,20,21], we investigated whether synaptic and biophysical properties of non-electroporated neurons nearby Rab27a shRNA-expressing neurons were altered. We examined L4 neurons because these neurons are born earlier than L2/3 neurons and as such, late-born neurons destined for L2/3 neurons migrate through deep cortical layers containing L4 neurons to reach their final location. In addition, the dendritic trees of L2/3 and L4 pyramidal neurons overlap during the neonatal period, and their axons travelled through each other’s dendritic tree and soma territories [32]. In addition, L4 neurons do not receive synaptic inputs from L2/3 neurons [33]. Patch-clamp recordings were obtained at P14 to examine potential changes in neuronal biophysical properties and synaptic inputs (Figure 2A). At this developmental age (P14), cortical pyramidal neurons are still acquiring dendritic spines (Supplementary Figure S2). Decreasing Rab27a levels in L2/3 neurons had no effect on the resting membrane potential, membrane resistance, and intrinsic excitability of L4 neurons (data not shown). However, it led to a significant increase in the frequency of sEPSCs in nearby L4 neurons without affecting their amplitude (Figure 2B,C). To evaluate spine properties, we used a dual IUE approach to conditionally express Rab27a shRNA in L2/3 neurons (E15.5 IUE) and DsRed in L4 neurons in the same animal using an inducible vector and Dcx-Cre (E13.5 IUE, Figure 2D). Expressing Rab27a shRNA in L2/3 neurons significantly increased spine density in L4 neurons, including the density of mushroom spines, which are considered mature and stable spines (Figure 2E,F).
We next speculated that an increased number of excitatory synaptic inputs onto L4 neurons would lead to enhanced sensory responses upon whisker stimulation. L4 neurons in the somatosensory barrel cortex receive sensory information transmitted from the whiskers to the thalamus and provide a well-defined system to measure cellular responses to sensory inputs [34]. To test this, we placed P21 mice in an enriched environment to increase whisker stimulation and examined the number of L4 neurons immuno-positive for the immediate early gene c-Fos, a well-established read-out of neuronal activity [35] (Figure 3A,B). We found that reducing Rab27a expression in L2/3 neurons did not affect the anatomy of the barrels, but it led to a significant increase in the number of c-Fos-positive L4 neurons in the barrel cortex following whisker stimulation (Figure 3C). Collectively, these data indicate that decreasing Rab27a levels had a non-cell autonomous effect on surrounding cortical neurons.

3.3. Decreasing Rab27a Levels in Cortical Neurons Reduces the Release of sEVs

Considering the non-cell-autonomous effects of Rab27a knockdown, we examined whether Rab27a controls the release of sEVs from neurons, as shown in non-neuronal cells [15,16,17,18,19,20,21]. To visualize MVBs in vivo, we used IUE at E15.5 to express tdTomato and a vector encoding CD63 fused to GFP. CD63 is expressed in MVB and intraluminal vesicles (ILs). At P7, CD63:GFP fluorescence was detected as puncta inside the soma and dendrites of tdTomato-positive pyramidal neurons, as expected, based on the known localization of MVBs [36] (Figure 4A). Immunostaining for Rab27a and CD63 revealed that Rab27a expression was associated with, and surrounded, CD63-positive puncta in P7 cortical neurons (Figure 4B). These data are consistent with Rab27a being involved in the fusion of MVBs with the plasma membrane, but not being contained inside MVBs or ILs [37]. Importantly, Rab27a knockdown led to an increase in the number of CD63-positive vesicles (Figure 4C,D), suggesting the accumulation and decreased release of IL/sEV. To further confirm this interpretation, we performed in vitro experiments. First, we examined at which time points in cultured cortical neurons (from days in vitro (DIV) 3 to 18) Rab27a levels were the highest. Using immunoblotting, Rab27a expression was the highest at DIV 3 and progressively decreased as neurons matured, consistent with the low expression in adult brains (Figure 4E,F). Next, we examined the effect of Rab27a knockdown on the release of sEVs at DIV 3. To isolate sEVs, the extracellular medium of DIV 3 cortical neurons was collected and subjected to filtration and sequential centrifugations [37,38]. The isolated vesicles in the sEV fraction contained nano-sized sEVs (also known as exosomes) based on their mean diameter (range: 60–115 nm, Figure 4G, smaller than the diameter of shedding microvesicles and apoptotic bodies [18,19,37,39,40,41,42]), their cup-like morphology assessed by electron microscopy (Figure 4H), and the presence of markers of MVB-generated sEVs, e.g., CD63 and Alix (Figure 4I) [37,43]. Nucleofection of Rab27a shRNA in primary cortical neurons reduced the amount of released Alix (normalized to GAPDH from cultured neurons), suggesting that reducing Rab27a levels decreases the quantity of released sEVs from cortical neurons (Figure 4J,K).

4. Discussion

Rab27a is one of two Rab27 small GTPases that are involved in intracellular vesicle trafficking. The role of Rab27a in the mammalian brain has not been examined, despite previous work showing a critical role of Rab27a in the development of synapses in invertebrates and the association of RAB27A copy number variations with simplex autism [9]. The lack of studies on Rab27a may stem from the fact that it was thought that Rab27a expression was very low in the adult brain [44,45]. Here, we confirmed that Rab27a levels are low in mature neurons compared to developing neurons in vitro. In particular, Rab27a levels progressively decreased as neurons acquired spines and synapses in vitro, suggesting that Rab27a expression may regulate spine development in a cell-autonomous manner. However, knocking down Rab27a in developing cortical neurons did not affect their spine and synapse development, suggesting that Rab27a does not regulate spine development in a cell-autonomous manner. However, Rab27a expression was decreased by about 50%, which may not be sufficient to affect neuronal development. Rab27b has been shown to compensate for the decrease in Rab27a in melanocytes of Rab27a knockout mice [45]. Here, we found no compensatory increase in Rab27b expression in cultured neurons expressing Rab27a shRNA. Collectively, decreasing Rab27a expression in cortical neurons had no net effect on the synaptic integration of Rab27a shRNA-expressing cortical neurons in vivo. In light of the known role of Rab27a in regulating sEV release, we next examined whether Rab27a knockdown would have a non-cell autonomous effect. Decreasing Rab27a levels in late-born L2/3 neurons led to a significant increase in excitatory synaptic activity as well as the density of dendritic spines in earlier born L4 neurons. Collectively, these data suggest that Rab27a controls a form of paracrine signal that limits spine development and excitatory synaptic inputs across neuronal populations.
To examine one potential mechanism of this non-cell-autonomous effect, we examined and validated that Rab27a regulates sEV release. Rab27a-positive puncta in P7 cortical sections were in close proximity to CD63-positive puncta that labeled MVB, which have been shown to release sEVs. Knocking down Rab27a led to the accumulation of CD63-positive puncta in cortical neurons, as previously reported in HeLa-CIITA cells [15]. Although using a plasmid encoding CD63, which increases CD63 levels, would be an issue if studying the function of endogenous CD63, this is not the case here since we compare CD63:GFP expression under two conditions. In addition, considering that CD63:GFP and tdTomato expression are under the same CAG promoter and Rab27a shRNA had no effect on tdTomato expression, we do not expect an artifactual effect of Rab27a shRNA on the plasmid-driven expression of CD63:GFP. These data suggest that Rab27a knockdown results in a decrease in the release of sEVs. To further ascertain the in vivo data, we used an in vitro system and found that knocking down Rab27a in DIV 3 cortical neurons led to a significant decrease in the release of Alix-positive sEVs. These data suggest that Rab27a regulates intracellular CD63-positive vesicle trafficking and the release of sEVs in developing cortical neurons. This effect may contribute to the in vivo non-cell-autonomous effect of Rab27a shRNA on L4 neurons. Indeed, sEVs package molecules, including protein and microRNA that could influence spine and synapse development of neighboring neurons [24,40,46]. For example, in the Drosophila larval neuromuscular junction, exosome-mediated transport of Wnt signals coordinates the development of pre- and post-synaptic components [47,48]. A recent study also reported that treatment with sEVs (exosomes) isolated from human-induced pluripotent stem cell (hiPSC)-derived neurons increase synapse density in hiPSC-derived neurospheres [23]. The molecules involved in this regulation were not examined, but the authors performed a proteomic screen that identified more than 2500 proteins in sEVs, providing potential candidates involved in spine regulation. Another recent study identified the presence of the epigenetic regulator HDAC2 in sEVs that regulated spine development in cultured cortical neurons [49]. Identifying the mechanisms of spine regulation by sEV (that include exosomes) in our system is outside the scope of the present study. Collectively, our findings show that Rab27a, possibly via regulating sEV release, controls a novel form of paracrine communication that precedes and regulates the establishment of synaptic transmission.

Supplementary Materials

The following are available online at https://www.mdpi.com/2073-4409/10/3/622/s1, Figure S1: Rab27a shRNA does not alter Rab27b levels in culture cortical neurons, Figure S2: Spine devel-opment is undergoing at P14, Table S1: List of plasmids, Table S2: List of antibodies.

Author Contributions

A.B. and L.Z. designed the experiments; L.Z. acquired most of the data; X.Z. and L.S.H. performed the patch-clamp experiments; T.V.L. designed vectors; A.B. and L.Z. wrote the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by CURE innovator award and NARSAD Distinguished investigator award funded by the Hofmann Trust, Tuberous Sclerosis Alliance (A.B.)

Institutional Review Board Statement

Research protocols were approved by the Yale University Institutional Animal Care and Use Committee.

Informed Consent Statement

Not applicable.

Acknowledgments

We thank Mueller (Scripps) for the Dcx-Cre construct, and other members of the lab for helpful discussion.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zhen, Y.; Stenmark, H. Cellular functions of Rab GTPases at a glance. J. Cell Sci. 2015, 128, 3171–3176. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Hutagalung, A.H.; Novick, P.J. Role of Rab GTPases in membrane traffic and cell physiology. Physiol. Rev. 2011, 91, 119–149. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Pfeffer, S.R. Rab GTPases: Master regulators that establish the secretory and endocytic pathways. Mol. Biol. Cell 2017, 28, 712–715. [Google Scholar] [CrossRef] [PubMed]
  4. Seabra, M.C.; Mules, E.H.; Hume, A.N. Rab GTPases, intracellular traffic and disease. Trends Mol. Med. 2002, 8, 23–30. [Google Scholar] [CrossRef]
  5. Fukuda, M. Regulation of secretory vesicle traffic by Rab small GTPases. Cell Mol. Life Sci. 2008, 65, 2801–2813. [Google Scholar] [CrossRef] [PubMed]
  6. Kiral, F.R.; Kohrs, F.E.; Jin, E.J.; Hiesinger, P.R. Rab GTPases and Membrane Trafficking in Neurodegeneration. Curr. Biol. 2018, 28, R471–R486. [Google Scholar] [CrossRef] [Green Version]
  7. Menasche, G.; Pastural, E.; Feldmann, J.; Certain, S.; Ersoy, F.; Dupuis, S.; Wulffraat, N.; Bianchi, D.; Fischer, A.; Le Deist, F.; et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat. Genet. 2000, 25, 173–176. [Google Scholar] [CrossRef]
  8. Meeths, M.; Bryceson, Y.T.; Rudd, E.; Zheng, C.; Wood, S.M.; Ramme, K.; Beutel, K.; Hasle, H.; Heilmann, C.; Hultenby, K.; et al. Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations. Pediatr. Blood Cancer 2010, 54, 563–572. [Google Scholar] [CrossRef]
  9. Krumm, N.; O’Roak, B.J.; Karakoc, E.; Mohajeri, K.; Nelson, B.; Vives, L.; Jacquemont, S.; Munson, J.; Bernier, R.; Eichler, E.E. Transmission disequilibrium of small CNVs in simplex autism. Am. J. Hum. Genet. 2013, 93, 595–606. [Google Scholar] [CrossRef] [Green Version]
  10. Mahoney, T.R.; Liu, Q.; Itoh, T.; Luo, S.; Hadwiger, G.; Vincent, R.; Wang, Z.W.; Fukuda, M.; Nonet, M.L. Regulation of synaptic transmission by RAB-3 and RAB-27 in Caenorhabditis elegans. Mol. Biol. Cell. 2006, 17, 2617–2625. [Google Scholar] [CrossRef] [Green Version]
  11. Yu, E.; Kanno, E.; Choi, S.; Sugimori, M.; Moreira, J.E.; Llinas, R.R.; Fukuda, M. Role of Rab27 in synaptic transmission at the squid giant synapse. Proc. Natl. Acad. Sci. USA 2008, 105, 16003–16008. [Google Scholar] [CrossRef] [Green Version]
  12. Chan, C.C.; Scoggin, S.; Wang, D.; Cherry, S.; Dembo, T.; Greenberg, B.; Jin, E.J.; Kuey, C.; Lopez, A.; Mehta, S.Q.; et al. Systematic discovery of Rab GTPases with synaptic functions in Drosophila. Curr. Biol. 2011, 21, 1704–1715. [Google Scholar] [CrossRef] [Green Version]
  13. Dillman, A.A.; Hauser, D.N.; Gibbs, J.R.; Nalls, M.A.; McCoy, M.K.; Rudenko, I.N.; Galter, D.; Cookson, M.R. mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex. Nat. Neurosci. 2013, 16, 499–506. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Miller, J.A.; Ding, S.L.; Sunkin, S.M.; Smith, K.A.; Ng, L.; Szafer, A.; Ebbert, A.; Riley, Z.L.; Royall, J.J.; Aiona, K.; et al. Transcriptional landscape of the prenatal human brain. Nature 2014, 508, 199–206. [Google Scholar] [CrossRef] [PubMed]
  15. Ostrowski, M.; Carmo, N.B.; Krumeich, S.; Fanget, I.; Raposo, G.; Savina, A.; Moita, C.F.; Schauer, K.; Hume, A.N.; Freitas, R.P.; et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 2010, 12, 19–30. [Google Scholar] [CrossRef] [Green Version]
  16. Hurley, J.H.; Odorizzi, G. Get on the exosome bus with ALIX. Nat. Cell Biol. 2012, 14, 654–655. [Google Scholar] [CrossRef]
  17. Kowal, J.; Tkach, M.; Thery, C. Biogenesis and secretion of exosomes. Curr. Opin. Cell Biol. 2014, 29, 116–125. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J.J.; Lotvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654–659. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Lee, Y.; El, A.S.; Wood, M.J. Exosomes and microvesicles: Extracellular vesicles for genetic information transfer and gene therapy. Hum. Mol. Genet. 2012, 21, R125–R134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Lawson, C.; Kovacs, D.; Finding, E.; Ulfelder, E.; Luis-Fuentes, V. Extracellular Vesicles: Evolutionarily Conserved Mediators of Intercellular Communication. Yale J. Biol. Med. 2017, 90, 481–491. [Google Scholar]
  21. Palmulli, R.; van Niel, G. To be or not to be... secreted as exosomes, a balance finely tuned by the mechanisms of biogenesis. Essays Biochem. 2018, 62, 177–191. [Google Scholar] [CrossRef] [PubMed]
  22. Lee, S.H.; Shin, S.M.; Zhong, P.; Kim, H.T.; Kim, D.I.; Kim, J.M.; Do Heo, W.; Kim, D.W.; Yeo, C.Y.; Kim, C.H.; et al. Reciprocal control of excitatory synapse numbers by Wnt and Wnt inhibitor PRR7 secreted on exosomes. Nat. Commun. 2018, 9, 3434. [Google Scholar] [CrossRef]
  23. Sharma, P.; Mesci, P.; Carromeu, C.; McClatchy, D.R.; Schiapparelli, L.; Yates, J.R., 3rd; Muotri, A.R.; Cline, H.T. Exosomes regulate neurogenesis and circuit assembly. Proc. Natl. Acad. Sci. USA 2019, 116, 16086–16094. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Zappulli, V.; Friis, K.P.; Fitzpatrick, Z.; Maguire, C.A.; Breakefield, X.O. Extracellular vesicles and intercellular communication within the nervous system. J. Clin. Investig. 2016, 126, 1198–1207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Budnik, V.; Ruiz-Canada, C.; Wendler, F. Extracellular vesicles round off communication in the nervous system. Nat. Rev. Neurosci. 2016, 17, 160–172. [Google Scholar] [CrossRef] [Green Version]
  26. Lin, T.V.; Hsieh, L.; Kimura, T.; Malone, T.J.; Bordey, A. Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration. Proc. Natl. Acad. Sci. USA 2016, 113, 11330–11335. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Pathania, M.; Torres-Reveron, J.; Yan, L.; Kimura, T.; Lin, T.V.; Gordon, V.; Teng, Z.Q.; Zhao, X.; Fulga, T.A.; Van, V.D.; et al. miR-132 enhances dendritic morphogenesis, spine density, synaptic integration, and survival of newborn olfactory bulb neurons. PLoS ONE 2012, 7, e38174. [Google Scholar] [CrossRef]
  28. Rodriguez, A.; Ehlenberger, D.B.; Dickstein, D.L.; Hof, P.R.; Wearne, S.L. Automated three-dimensional detection and shape classification of dendritic spines from fluorescence microscopy images. PLoS ONE 2008, 3, e1997. [Google Scholar] [CrossRef] [Green Version]
  29. Rochefort, N.L.; Konnerth, A. Dendritic spines: From structure to in vivo function. EMBO Rep. 2012, 13, 699–708. [Google Scholar] [CrossRef] [Green Version]
  30. Zhang, L.; Bartley, C.M.; Gong, X.; Hsieh, L.S.; Lin, T.V.; Feliciano, D.M.; Bordey, A. MEK-ERK1/2-Dependent FLNA Overexpression Promotes Abnormal Dendritic Patterning in Tuberous Sclerosis Independent of mTOR. Neuron 2014, 84, 78–91. [Google Scholar] [CrossRef] [Green Version]
  31. Ventura, A.; Meissner, A.; Dillon, C.P.; McManus, M.; Sharp, P.A.; Van Parijs, L.; Jaenisch, R.; Jacks, T. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 2004, 101, 10380–10385. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Feldmeyer, D.; Egger, V.; Lubke, J.; Sakmann, B. Reliable synaptic connections between pairs of excitatory layer 4 neurones within a single ’barrel’ of developing rat somatosensory cortex. J. Physiol. 1999, 521, 169–190. [Google Scholar] [CrossRef] [PubMed]
  33. Jiang, X.; Shen, S.; Cadwell, C.R.; Berens, P.; Sinz, F.; Ecker, A.S.; Patel, S.; Tolias, A.S. Principles of connectivity among morphologically defined cell types in adult neocortex. Science 2015, 350, aac9462. [Google Scholar] [CrossRef] [Green Version]
  34. Petersen, C.C. The barrel cortex--integrating molecular, cellular and systems physiology. Pflugers Arch 2003, 447, 126–134. [Google Scholar] [CrossRef] [Green Version]
  35. Bisler, S.; Schleicher, A.; Gass, P.; Stehle, J.H.; Zilles, K.; Staiger, J.F. Expression of c-Fos, ICER, Krox-24 and JunB in the whisker-to-barrel pathway of rats: Time course of induction upon whisker stimulation by tactile exploration of an enriched environment. J. Chem. Neuroanat. 2002, 23, 187–198. [Google Scholar] [CrossRef]
  36. Von Bartheld, C.S.; Altick, A.L. Multivesicular bodies in neurons: Distribution, protein content, and trafficking functions. Prog. Neurobiol. 2011, 93, 313–340. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Jeppesen, D.K.; Fenix, A.M.; Franklin, J.L.; Higginbotham, J.N.; Zhang, Q.; Zimmerman, L.J.; Liebler, D.C.; Ping, J.; Liu, Q.; Evans, R.; et al. Reassessment of Exosome Composition. Cell 2019, 177, 428–445.e18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Zhang, H.; Freitas, D.; Kim, H.S.; Fabijanic, K.; Li, Z.; Chen, H.; Mark, M.T.; Molina, H.; Martin, A.B.; Bojmar, L.; et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 2018, 20, 332–343. [Google Scholar] [CrossRef]
  39. Couzin, J. Cell biology: The ins and outs of exosomes. Science 2005, 308, 1862–1863. [Google Scholar] [CrossRef]
  40. Janas, A.M.; Sapon, K.; Janas, T.; Stowell, M.H.; Janas, T. Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseases. Biochim. Biophys. Acta 2016, 1858, 1139–1151. [Google Scholar] [CrossRef]
  41. Thery, C.; Ostrowski, M.; Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9, 581–593. [Google Scholar] [CrossRef]
  42. Dujardin, S.; Begard, S.; Caillierez, R.; Lachaud, C.; Delattre, L.; Carrier, S.; Loyens, A.; Galas, M.C.; Bousset, L.; Melki, R.; et al. Ectosomes: A new mechanism for non-exosomal secretion of tau protein. PLoS ONE 2014, 9, e100760. [Google Scholar] [CrossRef] [PubMed]
  43. El-Andaloussi, S.; Lee, Y.; Lakhal-Littleton, S.; Li, J.; Seow, Y.; Gardiner, C.; Alvarez-Erviti, L.; Sargent, I.L.; Wood, M.J. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat. Protoc. 2012, 7, 2112–2126. [Google Scholar] [CrossRef] [PubMed]
  44. Seabra, M.C.; Ho, Y.K.; Anant, J.S. Deficient geranylgeranylation of Ram/Rab27 in choroideremia. J. Biol. Chem. 1995, 270, 24420–24427. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Barral, D.C.; Ramalho, J.S.; Anders, R.; Hume, A.N.; Knapton, H.J.; Tolmachova, T.; Collinson, L.M.; Goulding, D.; Authi, K.S.; Seabra, M.C. Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome. J. Clin. Investig. 2002, 110, 247–257. [Google Scholar] [CrossRef] [PubMed]
  46. Goldie, B.J.; Dun, M.D.; Lin, M.; Smith, N.D.; Verrills, N.M.; Dayas, C.V.; Cairns, M.J. Activity-associated miRNA are packaged in Map1b-enriched exosomes released from depolarized neurons. Nucleic Acids Res. 2014, 42, 9195–9208. [Google Scholar] [CrossRef] [Green Version]
  47. Korkut, C.; Ataman, B.; Ramachandran, P.; Ashley, J.; Barria, R.; Gherbesi, N.; Budnik, V. Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless. Cell 2009, 139, 393–404. [Google Scholar] [CrossRef] [Green Version]
  48. Korkut, C.; Li, Y.; Koles, K.; Brewer, C.; Ashley, J.; Yoshihara, M.; Budnik, V. Regulation of postsynaptic retrograde signaling by presynaptic exosome release. Neuron 2013, 77, 1039–1046. [Google Scholar] [CrossRef] [Green Version]
  49. Zhang, L.; Lin, T.V.; Yuan, Q.; Sadoul, R.; Lam, T.T.; Bordey, A. Small extracellular vesicles control dendritic spine development through regulation of HDAC2 signaling. J. Neuro Sci. 2020, in press. [Google Scholar]
Figure 1. Rab27a knockdown does not affect cortical neuron placement and excitatory synaptic integration in a cellautonomous manner. (A) Diagram of the experimental paradigm. IUE: in utero electroporation. (B) Immunoblots of Rab27a, GAPDH from neurons containing empty vector (EV, control) or Rab27a shRNA and quantification of the blots shown in (A). ttest, N = 3 sets of cultures. (C) Images of tdTomato fluorescence and Cre immunostaining in coronal section from a (postnatal day) P14 mouse electroporated at embryonic day (E) 15 with Dcx-Cre, tdTomato, and Rab27 shRNA. (D,E) Z-stack images of tdTomato fluorescence, DAPI, and Rab27a immunostaining in coronal sections from P14 mice electroporated with either control or Rab27a shRNA (D). Plots of the normalized Rab27a intensity per cell in both conditions (E). (F) Top: images of Cux1 immunostaining and GFP+ neurons containing control or Rab27a shRNA in coronal sections from P14 mice. Blue: DAPI overlay. Bottom: graph of the % of GFP+ neurons expressing Cux1 and in layer (L) 2/3, the placement of neurons electroporated at E15.5. (G) Bar graphs of the mean resting membrane potentials (RMP) and input resistance of neurons expressing control or Rab27a shRNA. (H) Representative current-induced firing of recorded neurons and resulting input–output curves in both conditions. (I) Representative recordings of sEPSCs in neurons containing control or Rab27a shRNA and bar graphs of sEPSC frequency in both conditions. (J) Images of spines in each condition, and density of spines (all types) and of each individual type of spines in GFP+ neurons containing control (n = 21) or Rab27a (n = 26) shRNA. (K) Images of tdTomato+ neurons co-expressing ChR2 with control or Rab27a shRNA. The green circles delineate recorded neurons. Cortical neurons were nucleofected with Rab27a or control shRNA, and a plasmid encoding channelrhodopsin (ChR2) fused to mCherry. After plating, non-mCherry neurons were recorded at DIV 14 while light stimulation triggered spiking of ChR2-exressing neurons, resulting in synaptic release. (L) Representative examples of paired pulse traces induced by light stimulation of ChR2 in tdTomato+ neurons expressing control or Rab27a shRNA that are neighboring recorded neurons. (M) Plots of the mean paired pulse ratio. n = 9 neurons in control condition and n = 13 neurons in the Rab27a shRNA condition. Unpaired t-test and one-way ANOVA, ns: not significant and ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bars: 200 µm (C), 30 µm (D), 100 µm (F), 50 mV, 200 ms (H), 20 pA, 200 ms (I), 2.5 µm (J), 25 µm (K), and 50 pA, 100 ms (L). Plots are mean ± SEM including data points.
Figure 1. Rab27a knockdown does not affect cortical neuron placement and excitatory synaptic integration in a cellautonomous manner. (A) Diagram of the experimental paradigm. IUE: in utero electroporation. (B) Immunoblots of Rab27a, GAPDH from neurons containing empty vector (EV, control) or Rab27a shRNA and quantification of the blots shown in (A). ttest, N = 3 sets of cultures. (C) Images of tdTomato fluorescence and Cre immunostaining in coronal section from a (postnatal day) P14 mouse electroporated at embryonic day (E) 15 with Dcx-Cre, tdTomato, and Rab27 shRNA. (D,E) Z-stack images of tdTomato fluorescence, DAPI, and Rab27a immunostaining in coronal sections from P14 mice electroporated with either control or Rab27a shRNA (D). Plots of the normalized Rab27a intensity per cell in both conditions (E). (F) Top: images of Cux1 immunostaining and GFP+ neurons containing control or Rab27a shRNA in coronal sections from P14 mice. Blue: DAPI overlay. Bottom: graph of the % of GFP+ neurons expressing Cux1 and in layer (L) 2/3, the placement of neurons electroporated at E15.5. (G) Bar graphs of the mean resting membrane potentials (RMP) and input resistance of neurons expressing control or Rab27a shRNA. (H) Representative current-induced firing of recorded neurons and resulting input–output curves in both conditions. (I) Representative recordings of sEPSCs in neurons containing control or Rab27a shRNA and bar graphs of sEPSC frequency in both conditions. (J) Images of spines in each condition, and density of spines (all types) and of each individual type of spines in GFP+ neurons containing control (n = 21) or Rab27a (n = 26) shRNA. (K) Images of tdTomato+ neurons co-expressing ChR2 with control or Rab27a shRNA. The green circles delineate recorded neurons. Cortical neurons were nucleofected with Rab27a or control shRNA, and a plasmid encoding channelrhodopsin (ChR2) fused to mCherry. After plating, non-mCherry neurons were recorded at DIV 14 while light stimulation triggered spiking of ChR2-exressing neurons, resulting in synaptic release. (L) Representative examples of paired pulse traces induced by light stimulation of ChR2 in tdTomato+ neurons expressing control or Rab27a shRNA that are neighboring recorded neurons. (M) Plots of the mean paired pulse ratio. n = 9 neurons in control condition and n = 13 neurons in the Rab27a shRNA condition. Unpaired t-test and one-way ANOVA, ns: not significant and ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bars: 200 µm (C), 30 µm (D), 100 µm (F), 50 mV, 200 ms (H), 20 pA, 200 ms (I), 2.5 µm (J), 25 µm (K), and 50 pA, 100 ms (L). Plots are mean ± SEM including data points.
Cells 10 00622 g001
Figure 2. Rab27a knockdown in L2/3 (late-born) neurons alters glutamatergic transmission in L4 (earlier born) pyramidal neurons. (A) Confocal images illustrating GFP+ L2/3 neurons (IUE at E15.5 with GFP) and diagram of a patch pipette over L4. (B) Representative whole-cell patch-clamp recordings at −70 mV of L4 pyramidal neurons in P14 acute slices containing GFP+ L2/3 neurons expressing empty vector (EV, control) or Rab27a shRNA. (C) Bar graphs of the sEPSC frequencies (n = 15–21 L4 neurons for each condition). Unpaired t-test. (D) Confocal images illustrating GFP+ L2/3 neurons (IUE at E15.5 with GFP) and DsRed+ L4 neurons (IUE at E13.5 with an inducible DsRed vector (pCALNL-DsRed) and low concentration of Dcx-Cre). (E and F) Images of spines (E) and quantification (F) of spine density (all types) and each type in DsRed+ neurons in P14 slices containing GFP+ neurons expressing either control (n = 36 neurons) or Rab27a (n = 29) shRNA (4 mice per condition). Unpaired Student’s t-test and one-way ANOVA with Tukey’s post-hoc test. Unpaired t-test. Plots are mean ± SEM. ****: p < 0.0001, ***: p < 0.001, **: p < 0.01, and ns: not significant. Scale bars: 100 µm (A), 20 pA, 250 ms (B), and 2 µm (E).
Figure 2. Rab27a knockdown in L2/3 (late-born) neurons alters glutamatergic transmission in L4 (earlier born) pyramidal neurons. (A) Confocal images illustrating GFP+ L2/3 neurons (IUE at E15.5 with GFP) and diagram of a patch pipette over L4. (B) Representative whole-cell patch-clamp recordings at −70 mV of L4 pyramidal neurons in P14 acute slices containing GFP+ L2/3 neurons expressing empty vector (EV, control) or Rab27a shRNA. (C) Bar graphs of the sEPSC frequencies (n = 15–21 L4 neurons for each condition). Unpaired t-test. (D) Confocal images illustrating GFP+ L2/3 neurons (IUE at E15.5 with GFP) and DsRed+ L4 neurons (IUE at E13.5 with an inducible DsRed vector (pCALNL-DsRed) and low concentration of Dcx-Cre). (E and F) Images of spines (E) and quantification (F) of spine density (all types) and each type in DsRed+ neurons in P14 slices containing GFP+ neurons expressing either control (n = 36 neurons) or Rab27a (n = 29) shRNA (4 mice per condition). Unpaired Student’s t-test and one-way ANOVA with Tukey’s post-hoc test. Unpaired t-test. Plots are mean ± SEM. ****: p < 0.0001, ***: p < 0.001, **: p < 0.01, and ns: not significant. Scale bars: 100 µm (A), 20 pA, 250 ms (B), and 2 µm (E).
Cells 10 00622 g002
Figure 3. Decreasing Rab27a in L2/3 neurons leads to an increase in the number of L4 neurons activated by Whisker stimulation. (A) Images of c-fos (green), vesicular glutamate transporter 2 (VGLUT2) (red), and GFP (pseudo-colored blue) in slices from mice electroporated with EV or Rab27a shRNA in L2/3 neurons. (B) Zoom of c-fos and VGLUT2 images in the white rectangle in (A). (C) Bar graph of the cross-sectional area of barrels and the density of c-fos+ cells under both conditions (n = 4 mice with EV and n = 5 mice with Rab27a shRNA, n = 23 slices in each condition). The barrels were delineated using VGLUT2 immunostaining. Unpaired t-test. Plots are mean ± SEM including data points. ****: p < 0.0001 and ns: not significant. Scale bars: 100 µm (A) and 80 µm (B).
Figure 3. Decreasing Rab27a in L2/3 neurons leads to an increase in the number of L4 neurons activated by Whisker stimulation. (A) Images of c-fos (green), vesicular glutamate transporter 2 (VGLUT2) (red), and GFP (pseudo-colored blue) in slices from mice electroporated with EV or Rab27a shRNA in L2/3 neurons. (B) Zoom of c-fos and VGLUT2 images in the white rectangle in (A). (C) Bar graph of the cross-sectional area of barrels and the density of c-fos+ cells under both conditions (n = 4 mice with EV and n = 5 mice with Rab27a shRNA, n = 23 slices in each condition). The barrels were delineated using VGLUT2 immunostaining. Unpaired t-test. Plots are mean ± SEM including data points. ****: p < 0.0001 and ns: not significant. Scale bars: 100 µm (A) and 80 µm (B).
Cells 10 00622 g003
Figure 4. Rab27a regulates the release of small extracellular vesicles (sEVs) from developing cortical neurons. (A) Image of CD63:GFP and tdTomato fluorescence in late-born pyramidal neurons at P7 following IUE at E15. (B) Co-immunostaining for CD63 (red) and Rab27a (green) in a pyramidal neuron (P7 coronal section). (C) tdTomato and CD63:GFP fluorescence in pyramidal neurons from P7 mice that received CD63:GFP and either empty vector (control) or Rab27a shRNA following IUE at E15.5. (D) Plot of the normalized area occupied by CD63 immunostaining. (E,F) Immunoblots for Rab27a and GAPDH (E) from primary cortical neurons at different DIV and quantification of the blots (F). (G) Histogram of size distribution of sEVs determined by Nanoparticle Tracking Analysis. (H) Electron micrographs of purified sEVs. (I) Immunoblots for markers of sEVs. (J,K) Immunoblots of Alix from sEVs and GAPDH from neurons containing control (empty) shRNA vector or Rab27a shRNA (J), and quantification of the blots (K). These data were from the same cell cultures performed for Figure 1B. Plots are mean ± SEM. **: p < 0.01, ***: p < 0.001, ****: p < 0.0001, and ns: not significant, Student’s t-test. Scale bars: 15 µm (A,C), 7 µm (B), and 125 µm (H).
Figure 4. Rab27a regulates the release of small extracellular vesicles (sEVs) from developing cortical neurons. (A) Image of CD63:GFP and tdTomato fluorescence in late-born pyramidal neurons at P7 following IUE at E15. (B) Co-immunostaining for CD63 (red) and Rab27a (green) in a pyramidal neuron (P7 coronal section). (C) tdTomato and CD63:GFP fluorescence in pyramidal neurons from P7 mice that received CD63:GFP and either empty vector (control) or Rab27a shRNA following IUE at E15.5. (D) Plot of the normalized area occupied by CD63 immunostaining. (E,F) Immunoblots for Rab27a and GAPDH (E) from primary cortical neurons at different DIV and quantification of the blots (F). (G) Histogram of size distribution of sEVs determined by Nanoparticle Tracking Analysis. (H) Electron micrographs of purified sEVs. (I) Immunoblots for markers of sEVs. (J,K) Immunoblots of Alix from sEVs and GAPDH from neurons containing control (empty) shRNA vector or Rab27a shRNA (J), and quantification of the blots (K). These data were from the same cell cultures performed for Figure 1B. Plots are mean ± SEM. **: p < 0.01, ***: p < 0.001, ****: p < 0.0001, and ns: not significant, Student’s t-test. Scale bars: 15 µm (A,C), 7 µm (B), and 125 µm (H).
Cells 10 00622 g004
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zhang, L.; Zhang, X.; Hsieh, L.S.; Lin, T.V.; Bordey, A. Rab27a-Dependent Paracrine Communication Controls Dendritic Spine Formation and Sensory Responses in the Barrel Cortex. Cells 2021, 10, 622. https://doi.org/10.3390/cells10030622

AMA Style

Zhang L, Zhang X, Hsieh LS, Lin TV, Bordey A. Rab27a-Dependent Paracrine Communication Controls Dendritic Spine Formation and Sensory Responses in the Barrel Cortex. Cells. 2021; 10(3):622. https://doi.org/10.3390/cells10030622

Chicago/Turabian Style

Zhang, Longbo, Xiaobing Zhang, Lawrence S. Hsieh, Tiffany V. Lin, and Angélique Bordey. 2021. "Rab27a-Dependent Paracrine Communication Controls Dendritic Spine Formation and Sensory Responses in the Barrel Cortex" Cells 10, no. 3: 622. https://doi.org/10.3390/cells10030622

APA Style

Zhang, L., Zhang, X., Hsieh, L. S., Lin, T. V., & Bordey, A. (2021). Rab27a-Dependent Paracrine Communication Controls Dendritic Spine Formation and Sensory Responses in the Barrel Cortex. Cells, 10(3), 622. https://doi.org/10.3390/cells10030622

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop